Skip to main content

Table 1 Demographic and clinical characteristics in patients with cryptococcal meningitis

From: The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study

Variables

All (N = 150)

(n,%)

Good outcome (N = 94)

(n,%)

Bad outcome (N = 56)

(n,%)

P-value

Male

98 (65.33)

58 (61.70)

40 (71.43)

0.288

Age

  ≤ 30

31 (20.67)

26 (27.66)

5 (8.93)

0.000

 31–60

91 (60.67)

59 (62.77)

32 (57.14)

 >60

28 (18.67)

9 (9.57)

19 (33.93)

Presenting symptoms and signs

 Headache

136 (90.67)

89 (94.68)

47 (83.93)

0.029

 Vomiting

78 (52.00)

46 (48.94)

32 (57.14)

0.331

 Fever

74 (49.33)

52 (55.32)

22 (39.29)

0.057

 Altered mentation

31 (20.67)

12 (12.77)

19 (33.93)

0.002

 Abnormal vision

29 (19.33)

20 (21.28)

9 (16.07)

0.435

 Cough

12 (8.00)

7 (7.45)

5 (8.93)

0.746

 Abnormal hearing

9 (6.00)

5 (5.32)

4 (7.14)

0.726

 Seizure

7 (4.67)

4 (4.26)

3 (5.36)

1.000

Underlying diseases or factors

 HIV infection

32 (21.33)

8 (8.51)

24 (42.86)

0.000

 Immune system disease

16 (10.67)

12 (12.77)

4 (7.14)

0.413

 Hepatobiliary diseases

14 (9.33)

11 (11.70)

3 (5.36)

0.170

 Hypertension

13 (8.67)

9 (9.57)

4 (7.14)

0.768

 Corticosteroid medication or immunosuppressive drugs

15 (10.00)

9 (9.57)

6 (10.71)

0.822

 Diabetes mellitus

12 (8.00)

9 (9.57)

3 (5.36)

0.536

 Chronic lung disease

6 (4.00)

4 (4.26)

2 (3.57)

1.000

 Renal transplantation

7 (4.67)

4 (4.26)

3 (5.36)

1.000

 Tuberculosis

6 (4.00)

1 (1.06)

5 (1.79)

0.027

 Others

26 (17.92)

15 (15.96)

11 (19.64)

0.564

 None

32 (21.97)

25 (26.60)

7 (12.50)

0.042